Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-06-14T11:17:57.153Z

CUPID

CUPID
Prostate cancer

A phase I, single centre, open-label study of TLX592 to assess the safety and tolerability, pharmacokinetics, biodistribution and radiation dosimetry in patients diagnosed with prostate cancer.

A phase I, single centre, open-label study of TLX592 to assess the safety and tolerability, pharmacokinetics, biodistribution and radiation dosimetry in patients diagnosed with prostate cancer.

Trial overview

Clinical Area

Theranostics

Disease / Condition

Prostate Cancer

Study Phase

I

Trial Identifiers

NCT04726033

https://clinicaltrials.gov/study/NCT04726033

GenesisCare Location(s)
Principal Investigator(s)

Dr Anne Capp & Dr Aviral Singh

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.